FindTrial
Sign In

Traditional Chinese Medicine for the Treatment of COVID 19 (Omicron): A Registry Study

Traditional Chinese Medicine for the Treatment of COVID 19 (Omicron): A Registry Study

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ITMCTR
Registry ID
ITMCTR2200005800
Enrollment
Unknown
Registered
2022-04-03
Start date
2022-03-16
Completion date
Unknown
Last updated
2023-02-20

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Covid 19 (Omicron)

Interventions

None:Traditional Chinese Medicine

Sponsors

The Affiliated Hospital of Changchun University of Chinese Medicine
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1. Patients who meet the diagnostic criteria for mild and moderate types of COVID-19 in the "Diagnosis and Treatment Program for Novel Coronavirus Pneumonia (Trial Ninth Version)"; 2. Local cases and related cases in Jilin Province that appeared after March 1, 2022; 3. Patients are managed by the medical team of the Affiliated Hospital of Changchun University of Chinese Medicine; 4. Sign the informed consent.

Exclusion criteria

Exclusion criteria: 1. Patients without medical information; 2. Suspected and imported cases; 3. Pregnant women, pregnant or lactating women; 4. Patients with previous allergy to traditional Chinese medicine.

Design outcomes

Secondary

MeasureTime frame
Intervention Information;Outcomes;Demographic Information;—

Countries

China

Contacts

Public ContactWang Tan
1357979767@qq.com+86 15904312786

Outcome results

None listed

Source: ITMCTR (via WHO ICTRP) · Data processed: Feb 4, 2026